Similar Items: Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018–2023)
- Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Study
- Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Navigating the Evolution of Urothelial Carcinoma Treatment: From Chemotherapy to Immunotherapy
- Evolving Concepts in Salivary Duct Carcinoma: A Narrative Review
- Predictors of Hospitalization due to Febrile Neutropenia in Cancer Patients Receiving Chemotherapy
- Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy